Fermenta Biotech Limited (BOM:506414)

Market Cap	8.55B
Revenue (ttm)	4.27B
Net Income (ttm)	355.32M
Shares Out	29.43M
EPS (ttm)	12.26
PE Ratio	23.69
Forward PE	n/a
Dividend	1.25 (0.43%)
Ex-Dividend Date	Aug 6, 2024

Volume	10,481
Average Volume	26,459
Open	274.40
Previous Close	275.00
Day's Range	268.00 - 278.95
52-Week Range	145.00 - 449.00
Beta	0.04
RSI	54.67
Earnings Date	May 30, 2025

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, enzymes in India, Europe, the United States, and internationally. The company engages in the pharmaceutical formulations and environmental solutions; rents and sales properties; and sports and health awareness/education activities. It offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder used in applications, such as pharmaceuticals, dietary and nutritional supplements, fe...

• Industry: Pharmaceutical Preparations
• Founded: 1951
• Employees: 558
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506414

Financial Performance

In 2023, Fermenta Biotech's revenue was 3.36 billion, a decrease of -4.08% compared to the previous year's 3.50 billion. Losses were -230.60 million, -54.85% less than in 2022.